Assignee
NEURENDO PHARMA LLC
US·4 granted patents·2 pending applications·12 citations·filing 2007–2018
Top patents by PatentIndex Score
6 records- 0188US7893080B2Method of restoring the incretin effectNEURENDO PHARMA LLC·Filed 2007·Granted Feb 22, 2011·7 cites·18 claims
- 0286US8829018B2Method of restoring the incretin effectNEURENDO PHARMA LLC·Filed 2013·Granted Sep 9, 2014·5 cites·7 claims
- 0368US9987268B2Method of restoring the incretin effectNEURENDO PHARMA LLC·Filed 2014·Granted Jun 5, 2018·0 cites·8 claims
- 0466US2019134023A1Method of Restoring the Incretin EffectNEURENDO PHARMA LLC·Filed 2018·Application pending·0 cites
- 0565US8785469B2Method of treating atherogenic dyslipidemiaNEURENDO PHARMA LLC·Filed 2013·Granted Jul 22, 2014·0 cites·8 claims
- 0665US2014329844A1Method of restoring the incretin effectNEURENDO PHARMA LLC·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →